| Circulating tumor cells count as a predictor of survival in lung cancer K Syrigos, O Fiste, A Charpidou, D Grapsa Critical reviews in oncology/hematology 125, 60-68, 2018 | 49 | 2018 |
| Occupational exposure and multiple myeloma risk: An updated review of meta-analyses R Georgakopoulou, O Fiste, TN Sergentanis, A Andrikopoulou, F Zagouri, ... Journal of Clinical Medicine 10 (18), 4179, 2021 | 29 | 2021 |
| The emerging role of immunotherapy in intrahepatic cholangiocarcinoma O Fiste, I Ntanasis-Stathopoulos, M Gavriatopoulou, M Liontos, ... Vaccines 9 (5), 422, 2021 | 23 | 2021 |
| SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors F Zagouri, E Terpos, O Fiste, M Liontos, A Briasoulis, I Katsiana, E Skafida, ... The Breast 60, 58-61, 2021 | 19 | 2021 |
| Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy M Liontos, A Andrikopoulou, K Koutsoukos, C Markellos, E Skafida, ... Journal of ovarian research 14, 1-10, 2021 | 19 | 2021 |
| Immunological response to COVID-19 vaccination in ovarian cancer patients receiving PARP inhibitors M Liontos, E Terpos, C Markellos, F Zagouri, A Briasoulis, I Katsiana, ... Vaccines 9 (10), 1148, 2021 | 17 | 2021 |
| Pembrolizumab in endometrial cancer: where we stand now A Aravantinou-Fatorou, A Andrikopoulou, M Liontos, O Fiste, ... Oncology Letters 22 (6), 821, 2021 | 16 | 2021 |
| Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: A narrative review O Fiste, M Liontos, K Koutsoukos, E Terpos, MA Dimopoulos, F Zagouri Annals of Translational Medicine 8 (23), 2020 | 15 | 2020 |
| Overweight/obesity and monoclonal gammopathy of undetermined significance R Georgakopoulou, A Andrikopoulou, TN Sergentanis, O Fiste, F Zagouri, ... Clinical Lymphoma Myeloma and Leukemia 21 (6), 361-367, 2021 | 14 | 2021 |
| Artificial Intelligence-Based Treatment Decisions: A New Era for NSCLC O Fiste, I Gkiozos, A Charpidou, NK Syrigos Cancers 16 (4), 831, 2024 | 13 | 2024 |
| Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients M Liontos, E Terpos, E Kunadis, F Zagouri, A Briasoulis, E Skafida, ... Prostate Cancer and Prostatic Diseases 25 (1), 117-118, 2022 | 12 | 2022 |
| Assessment of the efficacy and clinical utility of different circulating tumor cell (CTC) detection assays in patients with chemotherapy-naive advanced or metastatic non-small … MA Papadaki, I Messaritakis, O Fiste, J Souglakos, E Politaki, A Kotsakis, ... International Journal of Molecular Sciences 22 (2), 925, 2021 | 12 | 2021 |
| Aromatase and CDK4/6 inhibitor-induced musculoskeletal symptoms: a systematic review A Andrikopoulou, O Fiste, M Liontos, MA Dimopoulos, F Zagouri Cancers 13 (3), 465, 2021 | 11 | 2021 |
| SARS-CoV-2 neutralizing antibodies kinetics postvaccination in cancer patients under treatment with immune checkpoint inhibition E Terpos, M Liontos, O Fiste, F Zagouri, A Briasoulis, AD Sklirou, ... Cancers 14 (11), 2796, 2022 | 10 | 2022 |
| Machine learning applications in gynecological cancer: a critical review O Fiste, M Liontos, F Zagouri, G Stamatakos, MA Dimopoulos Critical Reviews in Oncology/Hematology 179, 103808, 2022 | 7 | 2022 |
| Efficacy of NSCLC Rechallenge with Immune Checkpoint Inhibitors following Disease Progression or Relapse ME Livanou, V Nikolaidou, V Skouras, O Fiste, E Kotteas Cancers 16 (6), 1196, 2024 | 4 | 2024 |
| Paraneoplastic cerebellar degeneration in platinum-responsive endometrial cancer: a case report and review of literature M Liontos, O Fiste, D Drakopoulou, N Thomakos, K Goula, F Zagouri, ... Gynecologic Oncology Reports 37, 100826, 2021 | 4 | 2021 |
| Assessment of postvaccination neutralizing antibodies response against SARS-CoV-2 in cancer patients under treatment with targeted agents F Zagouri, A Papatheodoridi, M Liontos, A Briasoulis, AD Sklirou, ... Vaccines 10 (9), 1474, 2022 | 3 | 2022 |
| Advances in Gynecological Cancers M Liontos, O Fiste, F Zagouri, MA Dimopoulos International Journal of Molecular Sciences 23 (11), 6152, 2022 | 3 | 2022 |
| Oral SERDs alone or in combination with CDK 4/6 inhibitors in breast cancer: Current perspectives and clinical trials K Apostolidou, E Zografos, MA Papatheodoridi, O Fiste, MA Dimopoulos, ... The Breast, 103729, 2024 | 2 | 2024 |
